ETSI Officials Say IPR Policy A Foundation Of Successful Telecoms Standards 14/03/2016 by Dugie Standeford for Intellectual Property Watch Leave a Comment Standards developed by the European Telecommunications Standards Institute for industries such as the mobile communications sector are underlain by an intellectual property rights policy that has proved successful for many years, ETSI officials said at an 11 March Oxfirst webinar.
High-Level UN Initiative On Global Public Health Gap Holds Landmark Hearing 11/03/2016 by Catherine Saez and William New, Intellectual Property Watch 4 Comments An initiative of the United Nations secretary general yesterday gathered what could be described as an assembly of many of the world’s best thinkers and practitioners on public health and intellectual property rights. Industry, activists, academics, international organisations, and possibly some governments poured out their views for nearly seven hours – at times coming to tears and tension – shepherded by an astute moderator, as they responded to the call to take a longstanding debate on medicines access and high prices to a breakthrough.
MSF Challenges Pfizer Patent Application For Pneumonia Vaccine In India 11/03/2016 by Intellectual Property Watch 1 Comment Today, Médecins Sans Frontières (MSF, Doctors Without Borders) filed a patent opposition against Pfizer’s vaccine for pneumonia in India.
WHO Welcomes UN Secretary-General’s High-Level Panel, Offers Suggestions 10/03/2016 by William New, Intellectual Property Watch Leave a Comment The World Health Organization has provided a list of suggestions to the United Nations Secretary General’s High-Level Panel on Access to Medicines, highlighting WHO activities in this area and making suggestions on areas the WHO has not yet been able to complete. It also describes several new proposals by WHO, including a global “fair pricing forum,” a pooled health product R&D fund, and a global antibiotic research and development facility.
Civil Society Concerns Over US Health Service Plan To Give Exclusive Patent Rights To Sanofi 10/03/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The United States National Institutes of Health’s decision to consider granting an exclusive licence on patents for a newly government-developed vaccine to Sanofi has prompted a strong reaction from civil society warning against potential high prices and requesting transparency in the process.
Zika Virus R&D: No Vaccine Before 3 To 5 Years, Sample Sharing Needs Incentives 10/03/2016 by Catherine Saez, Intellectual Property Watch 2 Comments International experts convened by the World Health Organization this week on the Zika virus said vaccine development is a priority for the future but the most pressing need is to get diagnostic and prevention tools. Over 60 groups are hard at work on experimental products, according to the WHO, while a system of incentives to share virus samples is being considered.
Gilead Sovaldi Case Reveals Patent-Health Fissures In India 09/03/2016 by Patralekha Chatterjee for Intellectual Property Watch 2 Comments NEW DELHI — Are patient groups, health activists and manufacturers of low-cost generic drugs always on the same page? Do India’s generic companies think alike? The short answer: not necessarily, though their interests have overlapped on many occasions.
UN Global Dialogue On Innovation And Access To Medicines This Week 08/03/2016 by Intellectual Property Watch Leave a Comment The United Nations Secretary General’s High-Level Panel on Access to Medicines is holding a global dialogue this month, attended by governments, civil society, industry and academia, to discuss potential solutions to promote innovation and at the same time increase access to medicines. The first public dialogue session is this week, on 10 March in London.
WHO: Zika Virus Spreading, R&D Needs Financing, Sample Sharing Discussed 08/03/2016 by Catherine Saez, Intellectual Property Watch 5 Comments The World Health Organization said today that evidence of the relationship between the Zika virus and neonatal malformations and neurological disorders is growing stronger. The Emergency Committee set up by the WHO at a gathering today issued advice to the WHO director general, including warning pregnant women to avoid travelling to Zika infected countries. Meanwhile, discussions are ongoing on the sharing of the samples of the virus, and on the question of benefit-sharing. And a call was made for research and development to intensify.
As South Sudan Joins East African Community, Some Experts Worry Over Its IP Laws 08/03/2016 by Fredrick Nzwili for Intellectual Property Watch Leave a Comment NAIROBI, Kenya — Experts and activists are raising concern over the lack of proper intellectual property laws in South Sudan, as the world’s newest nation’s admission into the East Africa Community (EAC) spurs anticipation of increased investment.